USRE37793EExpiredUtility
Method and composition for inhibiting bacteria
Est. expiryApr 25, 2015(expired)· nominal 20-yr term from priority
Inventors:Philip Domenico
A61K 33/24A61K 33/245A61K 31/095
92
PatentIndex Score
47
Cited by
72
References
18
Claims
Abstract
A composition comprising a trivalent bismuth salt, particularly bismuth nitrate, and dimercaprol is described. Methods for using the composition as a bacteriocidal and bacteriostatic agent and as a disinfectant and preservative are also provided.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A composition, comprising:
a trivalent bismuth salt; and
at least one compound selected from the group consisting of dimercaprol, β-mercaptoethanol and dithiothreitol, wherein the molar ratio of said trivalent bismuth salt to said compound is approximately 1:2 to approximately 3:1. 1:1 to approximately 3:1.
2. A composition, as recited in claim 1 , wherein said trivalent bismuth salt is selected from the group consisting of bismuth nitrate, colloidal bismuth subcitrate and bismuth subsalicylate.
3. A composition, as recited in claim 1 , wherein said molar ratio is approximately 1:1 to approximately 3:1.
4. A composition, as recited in claim 1 , wherein said molar ratio is approximately 2:1 to approximately 3:1.
5. A composition, as recited in claim 1 , further comprising a pharmaceutically acceptable diluent or carrier.
6. A composition, comprising:
a trivalent bismuth salt; and
at least one compound selected from the group consisting of dimercaprol, β-mercaptoethanol and dithiothreitol, wherein said trivalent bismuth salt and said compound are present in the molar ratio of approximately 3:1.
7. A method of preventing or inhibiting bacterial infection, comprising the step of:
administering a therapeutically effective amount of a composition comprising a trivalent bismuth salt and at least one compound selected from the group consisting of dimercaprol, β-mercaptoethanol and dithiothreitol to a patient, in need thereof.
8. A method, as recited in claim 7 , wherein said trivalent bismuth salt is selected from the group consisting of bismuth nitrate, colloidal bismuth subcitrate and bismuth subsalicylate.
9. A method, as recited in claim 8 , wherein the molar ratio of said trivalent bismuth salt to said compound is not less than approximately 1:2 nor more than approximately 3:1.
10. A method, as recited in claim 9 , wherein said molar ratio is approximately 1:1 to approximately 3:1.
11. A method, as recited in claim 9 , wherein said molar ratio is approximately 2:1 to approximately 3:1.
12. A method of eradicating bacteria, comprising the step of:
applying to an area on which it is desired to eradicate bacteria on effective amount of a composition comprising a trivalent bismuth salt and at least one compound selected from the group consisting of dimercaprol, β-mercaptoethanol and dithiothreitol.
13. A method, as recited in claim 12 , wherein said trivalent bismuth salt is selected from the group consisting of bismuth nitrate, colloidal bismuth subcitrate and bismuth subsalicylate.
14. A method, as recited in claim 13 , wherein the molar ratio of said trivalent bismuth salt to said compound is not less than approximately 1:2 nor more than approximately 3:1.
15. A method, as recited in claim 14 , wherein said molar ratio is approximately 1:1 to approximately 3:1.
16. A method, as recited in claim 14 , wherein said molar ratio is approximately 2:1 to approximately 3:1.
17. A method of preventing the formation of growth of biofilms, comprising the step of:
applying to an area on which it is desired to prevent the formation or growth of biofilms an effective amount of a composition comprising a trivalent bismuth salt and at least one compound selected from the group consisting of dimercaprol, β-mercaptoethanol and dithiothreitol.
18. A method of preventing spoilage, comprising the step of:
applying to a product on which it is desired to prevent spoilage an effective amount of a composition comprising a trivalent bismuth salt and at least one compound selected from the group consisting of dimercaprol, β-mercaptoethanol and dithiothreitol.Join the waitlist — get patent alerts
Track USRE37793E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.